SCHEMBL28899776

SCHEMBL28899776

CONC(=N)N(OC)C(=N)Nc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PHGDH O43175 1/20 0.39
CYP1A2 P05177 2/20 0.37
CYP2C19 P33261 2/20 0.37
TAS2R38 P59533 3/20 0.36
HSD17B10 Q99714 3/20 0.36
ALDH1A1 P00352 3/20 0.36
TP53 P04637 2/20 0.36
TSHR P16473 2/20 0.36
TYR P14679 1/20 0.36
NAPRT Q6XQN6 1/20 0.36
HTT P42858 3/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
GAA P10253 2/20 0.35
CYP3A4 P08684 2/20 0.35
MAPT P10636 2/20 0.35
NPC1 O15118 1/20 0.35
CYP2C9 P11712 1/20 0.35
RAB9A P51151 1/20 0.35
LMNA P02545 1/20 0.35
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28960082 0.85 ALDH1A1 (0.41) PHGDHCYP1A2CYP2C19TAS2R38HSD17B10
SCHEMBL6695492 0.78 NAPRT (0.42) HSD17B10ALDH1A1TP53TSHRNAPRT
SCHEMBL10591421 0.74 PHGDH (0.47) PHGDHCYP1A2CYP2C19TAS2R38HSD17B10
SCHEMBL7711518 0.70 KMT2A (0.33) HSD17B10ALDH1A1TSHRSMN1; SMN2GAA
SCHEMBL2001630 0.70 TAS2R38 (0.46) TAS2R38HSD17B10ALDH1A1TP53TSHR
SCHEMBL14868313 0.68 TAS2R38 (0.45) TAS2R38HSD17B10ALDH1A1TP53TSHR
SCHEMBL28899654 0.68 ALDH1A1 (0.38) TAS2R38HSD17B10ALDH1A1TP53TSHR
SCHEMBL28899663 0.68 ALDH1A1 (0.38) TAS2R38HSD17B10ALDH1A1TP53TSHR
SCHEMBL9505592 0.68 TAS2R38 (0.48) PHGDHCYP1A2CYP2C19TAS2R38HSD17B10
SCHEMBL11413702 0.67 SMN1; SMN2 (0.64) HSD17B10ALDH1A1TP53TSHRNAPRT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115414480-A Dianhydrogalactitol in combination with radiation for treatment of non-small cell lung cancer and glioblastoma multiforme 德玛医药 2022-12-02 CN disclosed